vs
PTC THERAPEUTICS, INC.（PTCT）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是PTC THERAPEUTICS, INC.的1.3倍（$217.4M vs $164.7M），Rapid7, Inc.净利率更高（1.4% vs -82.0%，领先83.4%），Rapid7, Inc.同比增速更快（0.5% vs -22.7%），Rapid7, Inc.自由现金流更多（$36.4M vs $-36.6M），过去两年Rapid7, Inc.的营收复合增速更高（3.0% vs -11.5%）
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
PTCT vs RPD — 直观对比
营收规模更大
RPD
是对方的1.3倍
$164.7M
营收增速更快
RPD
高出23.3%
-22.7%
净利率更高
RPD
高出83.4%
-82.0%
自由现金流更多
RPD
多$73.1M
$-36.6M
两年增速更快
RPD
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $164.7M | $217.4M |
| 净利润 | $-135.0M | $3.1M |
| 毛利率 | — | 68.9% |
| 营业利润率 | -43.3% | 1.0% |
| 净利率 | -82.0% | 1.4% |
| 营收同比 | -22.7% | 0.5% |
| 净利润同比 | -104.8% | 44.1% |
| 每股收益（稀释后） | $-1.63 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTCTRPD
| Q4 25 | $164.7M | $217.4M | ||
| Q3 25 | $211.0M | $218.0M | ||
| Q2 25 | $178.9M | $214.2M | ||
| Q1 25 | $1.2B | $210.3M | ||
| Q4 24 | $213.2M | $216.3M | ||
| Q3 24 | $196.8M | $214.7M | ||
| Q2 24 | $186.7M | $208.0M | ||
| Q1 24 | $210.1M | $205.1M |
净利润PTCTRPD
| Q4 25 | $-135.0M | $3.1M | ||
| Q3 25 | $15.9M | $9.8M | ||
| Q2 25 | $-64.8M | $8.3M | ||
| Q1 25 | $866.6M | $2.1M | ||
| Q4 24 | $-65.9M | $2.2M | ||
| Q3 24 | $-106.7M | $15.4M | ||
| Q2 24 | $-99.2M | $6.5M | ||
| Q1 24 | $-91.6M | $1.4M |
毛利率PTCTRPD
| Q4 25 | — | 68.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | — | 70.6% | ||
| Q1 25 | — | 71.7% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 70.7% | ||
| Q1 24 | — | 70.3% |
营业利润率PTCTRPD
| Q4 25 | -43.3% | 1.0% | ||
| Q3 25 | 1.4% | 2.7% | ||
| Q2 25 | -19.5% | 1.6% | ||
| Q1 25 | 82.5% | -0.0% | ||
| Q4 24 | -76.2% | 3.4% | ||
| Q3 24 | -27.7% | 6.0% | ||
| Q2 24 | -21.5% | 2.5% | ||
| Q1 24 | -21.6% | 4.7% |
净利率PTCTRPD
| Q4 25 | -82.0% | 1.4% | ||
| Q3 25 | 7.5% | 4.5% | ||
| Q2 25 | -36.3% | 3.9% | ||
| Q1 25 | 73.7% | 1.0% | ||
| Q4 24 | -30.9% | 1.0% | ||
| Q3 24 | -54.2% | 7.2% | ||
| Q2 24 | -53.1% | 3.1% | ||
| Q1 24 | -43.6% | 0.7% |
每股收益（稀释后）PTCTRPD
| Q4 25 | $-1.63 | $0.05 | ||
| Q3 25 | $0.20 | $0.15 | ||
| Q2 25 | $-0.83 | $0.13 | ||
| Q1 25 | $10.04 | $0.03 | ||
| Q4 24 | $-0.85 | $0.08 | ||
| Q3 24 | $-1.39 | $0.21 | ||
| Q2 24 | $-1.29 | $0.09 | ||
| Q1 24 | $-1.20 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9B | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-205.3M | $154.7M |
| 总资产 | $2.9B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PTCTRPD
| Q4 25 | $1.9B | $474.7M | ||
| Q3 25 | $1.7B | $407.1M | ||
| Q2 25 | $2.0B | $511.7M | ||
| Q1 25 | $2.0B | $493.5M | ||
| Q4 24 | $1.1B | $521.7M | ||
| Q3 24 | $1.0B | $443.7M | ||
| Q2 24 | $1.1B | $442.6M | ||
| Q1 24 | $884.8M | $411.7M |
股东权益PTCTRPD
| Q4 25 | $-205.3M | $154.7M | ||
| Q3 25 | $-155.8M | $127.2M | ||
| Q2 25 | $-206.5M | $90.4M | ||
| Q1 25 | $-185.8M | $52.7M | ||
| Q4 24 | $-1.1B | $17.7M | ||
| Q3 24 | $-1.1B | $-5.1M | ||
| Q2 24 | $-980.2M | $-52.6M | ||
| Q1 24 | $-893.9M | $-86.4M |
总资产PTCTRPD
| Q4 25 | $2.9B | $1.7B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.6B | $1.6B | ||
| Q1 25 | $2.7B | $1.6B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.8B | $1.6B | ||
| Q2 24 | $1.9B | $1.5B | ||
| Q1 24 | $1.8B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-34.3M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $-36.6M | $36.4M |
| 自由现金流率自由现金流/营收 | -22.3% | 16.8% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | $702.3M | $146.2M |
8季度趋势，按日历期对齐
经营现金流PTCTRPD
| Q4 25 | $-34.3M | $37.6M | ||
| Q3 25 | $-66.3M | $39.0M | ||
| Q2 25 | $-58.3M | $47.5M | ||
| Q1 25 | $870.1M | $29.8M | ||
| Q4 24 | $-30.0M | $63.8M | ||
| Q3 24 | $-77.0M | $44.0M | ||
| Q2 24 | $-71.5M | $32.9M | ||
| Q1 24 | $70.8M | $31.1M |
自由现金流PTCTRPD
| Q4 25 | $-36.6M | $36.4M | ||
| Q3 25 | $-69.7M | $34.8M | ||
| Q2 25 | $-59.6M | $46.6M | ||
| Q1 25 | $868.4M | $28.4M | ||
| Q4 24 | $-33.8M | $62.6M | ||
| Q3 24 | $-77.5M | $42.6M | ||
| Q2 24 | $-78.8M | $32.6M | ||
| Q1 24 | $61.2M | $30.4M |
自由现金流率PTCTRPD
| Q4 25 | -22.3% | 16.8% | ||
| Q3 25 | -33.1% | 16.0% | ||
| Q2 25 | -33.3% | 21.8% | ||
| Q1 25 | 73.8% | 13.5% | ||
| Q4 24 | -15.8% | 28.9% | ||
| Q3 24 | -39.4% | 19.9% | ||
| Q2 24 | -42.2% | 15.7% | ||
| Q1 24 | 29.1% | 14.8% |
资本支出强度PTCTRPD
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 1.6% | 1.9% | ||
| Q2 25 | 0.7% | 0.4% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 1.8% | 0.5% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 4.0% | 0.1% | ||
| Q1 24 | 4.6% | 0.3% |
现金转化率PTCTRPD
| Q4 25 | — | 12.01× | ||
| Q3 25 | -4.17× | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | 1.00× | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTCT
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
